Training providers through STOP HCC

Bertha “Penny” Flores, PhD, APRN, WHNP-BC, assistant professor in the UT Health San Antonio School of Nursing, and her team have recently published a study in the Journal of Cancer Education demonstrating how the brief STOP HCC training can yield strong improvements in primary care provider knowledge and attitudes about hepatitis c testing and treatment. […]

Read more

New guidelines: All adults should be screened for HCV

The U.S. Preventive Services Task Force (USPSTF) has issued new recommendations to screen all adults aged 18-79 for HCV. This recommendation is based off of a systematic review, published in the Journal of the American Medical Association (JAMA), which reported that anti-viral therapies are very effective at curing patients, often short in course (8-12 weeks), […]

Read more
Couple talks to doctor

English and Spanish resources

Education is an important step towards better health. To help empower our community to make informed decisions about their own care, we have started a library of fact sheets on key points about hepatitis C. View our For Everyone page to view our selection of free fact sheets in English and Spanish. Looking for a […]

Read more
Hepatitis C virus

Liver cancer prevention in safety-net clinics

The UT Health San Antonio Newsroom recently highlighted the efforts of the STOP HCC program to screen, management, and treat HCV in settings serving disadvantaged patients. Read the article here. View our publication at the Annals of Internal Medicine.

Read more

HCV care support needed in vulnerable communities

A recent article by MedPage Today provides commentary and perspective on the December publication by our group in the Annals of Internal Medicine. F. Blaine Hollinger MD, at the Eugene B. Casey Hepatitis Research Center at Baylor College of Medicine in Houston offers commentary on the rates of chronic infection and identifies what we view […]

Read more
Annals of Internal Medicine

New publication about STOP HCC program

2.7-3.5 million people in the US have chronic HCV and roughly half don’t know it. This is particularly dangerous because HCV can develop into chronic liver disease and even liver cancer. A new publication from our group in the Annals of Internal Medicine describes the STOP HCC-HCV program to screen, manage, and treat HCV and […]

Read more
Screen treat and cure liver disease

Hep C treatment and liver cancer survival

Hepatitis C virus can lead to severe liver damage and hepatocellular carcinoma (HCC), a common corm of liver cancer. Researchers have long known that early detection and treatment of hepatitis C with direct-acting antiviral therapy (DAAs) can reduce the risks of developing HCC. Now there appears to be even more good news. Patients who have […]

Read more

Texas earns a D+

The National Viral Hepatitis Roundtable has released state-by-state report cards on Medicaid access, a major consideration for who can get access to hepatitis c testing treatment. The report takes a close look at treatment access in each state. The key restrictions that earned Texas a D+ grade are related to liver damage, sobriety, and prescriber […]

Read more

Should all adults be screened for Hepatitis C?

The United States Preventive Services Task Force (USPSTF) is considering a new recommendation to screen all adults aged 18-79 for hepatitis C virus (HCV). The USPSTF, a panel of national experts in prevention and medicine, previously recommended one-time, HCV screening for all persons born 1945-1965 (baby boomers) as well as individuals at risk for infection […]

Read more

Hepatitis C screening saves lives

HCV is the most common blood-borne infection in the US and a leading cause of liver failure and liver cancer. But most people who have it do not know they are infected. The good news is that HCV can be cured, often in just three months with daily medication.  Pharmaceutical assistance pathways offer free or […]

Read more